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Abstract 
 
Combination chemotherapy (co-chemotherapy) is a recent strategy to reduce the toxicity 
effect and increase the effectivity of chemotherapeutic agent, such as Doxorubicin (Dox). Caesalpinia 
sappan L. are potential to be developed as co-chemoterapeutic agents due to its strong cytotoxicity 
toward several breast cancer cells. The purpose of this research is to observe the cytotoxicity of 
Brazilein containing fraction (BCF) in single and its combination with doxorubicin on T47D cells. 
BCF was obtained by fractionation using chloroform:ethyl acetate (40:60 v/v) as mobile phase. 
Molecular docking results showed that Brazilein and Brazilin interacted with Bcl-2 with different 
binding properties. Based on MTT assay, Dox and BCF performed potent cytotoxicity with IC50 
value of 403 nM and 68 μg/mL, respectively. BCF increased the cytotoxicity of Dox and performed 
synergism with CI value <1 and decreased possible toxicity with DRI value>1. Under Annexin V PI 
staining Flowcytometry, BCF in single and its combination with doxorubicin induced apoptosis. In 
conclusion, single treatment of BCF and its combination with Dox performed cytotoxic effect and 
induced apoptosis on T47D cell lines. 
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INTRODUCTION 
 
The incidence of breast cancer cells increases 
gradually around the world. In Indonesia alone, 
there are 21.4% female patient was die caused by 
breast cancer (WHO, 2014). T47D cell is one of 
breast cancer cells with the character of p53 
mutation implicating in reducing or even loss of 
p53 ability for cell cycle regulation (Schafer, et al., 
2000). Possible strategy to overcome p53 mutated 
breast cancer cells was by the using of apoptosis 
inductor. Therefore, development of potent 
chemotherapy agents toward p53 mutated breast 
cancer cells is important to be explored. 
Doxorubicin (Dox) was a common 
chemotherapy and potent apoptosis inductor. 
However, Dox also possessed as a double-edged 
sword chemotherapy due to its non-selective strong 
cytotoxicity both on cancer and normal cells. ROS 
induction is one of cytotoxic mechanism of 
doxorubicin and played role on apoptosis induction 
(Wang, et al., 2004). However, increasing ROS 
accumulation effect by Dox also induces the 
occurrence of several side effect such as 
genotoxicity, hepatotoxicity, and neurotoxicity 
(Kalender, et al., 2005; Ramos, et al., 2011; 
Tangpong, et al., 2011). Strategic approach to 
prevent the side effect as well as to increase the 
cytotoxicity of doxorubicin is by using the 
combination chemotherapy or co-chemotherapeutic 
agent (Alison, 2004). Hence, several candidates of 
co-chemoterapeutic agents are developed in the 
further research. 
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Indonesian plants that had been explored as 
co-chemoterapeutic agent is secang (Caesalpinia 
sappan L. (CS)) (Wicaksono, et al., 2008). Nurulita 
and Muflih, (2006) reported that the IC50 of 
methanolic extract of CS was 150.9 µg/mL. 
Ethanolic extract of CS performed cytotoxic effect 
with IC50 of 35 µg/mL and increased cytotoxicity of 
doxorubicin through apoptosis induction  (Nurzijah, 
et al., 2012). Yen, et al., (2010) reported that 
Brazilein, one of active compound containing in CS 
performed cytotoxic effect on Hep G2 and Hep 3b 
(liver), MDA-MB-231 and MCF-7 (breast), A549 
(lung), and Ca9-22 (Oral) with IC50 value of 2-10 
µg/mL. Brazilin, another active compound 
containing in CS, induced apoptosis through 
inactivation of histone deacetylase in multiple 
myeloma U266 Cells (Kim, et al., 2012). However, 
another compound beside brazilein and brazilin 
such as sappanchalcone possessed proliferative 
activity and predicted to decrease the cytotoxic 
activity of CS (Subehan, et al., 2014). Therefore, 
the aim of this study is to determine the cytotoxicity 
of purified CS extract containing brazilein namely 
Brazilein containing extract (BCF) in single 
treatment and its combination with doxorubicin 
toward p53 mutated T47D cells. 
 
METHODS 
 
Sample Preparation 
Secang woods were obtained from 
B2P2TOOT Tawangmangu, Central Java. Dried 
powder of CS was extracted by 70% methanol, then 
it was fractinated using column chromatography 
using mobile phase composition of 
chloroform:ethyl acetate (40:60 v/v). Doxorubicin 
(Dox) was purchased by Sigma. 
 
Thin Layer Chromatography 
BCF was dilluted on methanol, then wass 
eluted on TLC by using silica gel F254 as a 
stationary phase and toluene:etyl acetate:methanol: 
formic acid (4:6:1:0,5 v/v/v) as a mobile phase. 
Brazilein from collection of Chemoprevention 
Research Center (CCRC) was used as reference 
standard. 
 
Molecular Docking 
Protein-Ligand Ant System (PLANTS) 1.1 
software was used as molecular docking software. 
The structure of Bcl-2 protein (PDB ID: 4MAN) 
was downloaded from PDB. MarvinSketch 
(http://www.chemaxon.com/marvin/download-user. 
html) was used brazilein and brazilin preparation. 
Yasara (http://www.yasara.org/viewdl.htm) was 
used for preparing Bcl-2 as protein target. 2D and 
3D visualization was performed by MOE 2010 
(Licensed from Faculty of Pharmacy UGM). 
 
Cell Culture 
T47D cells were collection of Cancer 
Chemoprevention Research Center (CCRC) Faculty 
of Pharmacy UGM (obtained from Nara Institute of 
Science and Technology (NAIST), Japan). 
Dulbecco’s Modified Eagle Medium (DMEM) 
1640 powder (Gibco) containing 10 % v/v Fetal 
Bovine Serum (FBS) (Gibco), 1,5% penicilin-
streptomycin  (Gibco), 0.5% fungizone (Gibco) 
were used for culture medium. Tripsin-EDTA 
(Gibco) 0.25% were used for cells preparation. 
 
Cytotoxicity assay 
Cytotoxicity assay was conducted according 
to Mosmann, (1983) with slight modification. Cells 
were planted on 96-well plate (Iwaki) in amount of 
8x103 cells/well then were incubated at 37oC 5% 
CO2 overnight. Each cells were treated with various 
concentration of BCF and Dox for 24 hours. Cells 
were incubated with 0.5 mg/mL MTT (Sigma) for 4 
hours, then 10%v/v SDS in 0.1N HCl (Merck) as 
stopper reagent was added. The absorbance was 
measured at λ of 595 nm by using ELISA reader 
(Bio-Rad). 
 
Apoptosis Assay 
An amount of 5x104 cells/well were 
transfered to 6-well plate (Iwaki) and incubated at 
37°C 5 % CO2 condition. Cells were treated by 
BCF, Dox, and their combination for 24 hours. 
Cells were centrifugated and added by 100 annexin 
V-FITC which was diluted in binding buffer. Cells 
were incubated for 15 minutes and analyzed with 
flowcytometry at λ of 488 nm. 
 
Data Analysis 
Molecular Docking. fPLP score was used as 
parameter of affinity, lower fPLP score indicated 
stronger affinity. Single Cytotoxicity assay. IC50 
value was used as parameter of cytotoxicity. 
Combinational Cytotoxicity Assay. Combination 
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Index (CI) value (CI>1, antagonism; CI=1, 
additive, CI<1, synergism) was used as parameter 
of cytotoxicity of combination while Dose 
Reduction Index (DRI) value (DRI>1, decreased 
toxicity) was used as parameter of toxicity 
prediction (Chou, 2010). Apoptosis Assay. Cells on 
each quadrant represented as viable cells (lower 
left), early apoptosis (lower right), late apoptosis 
(upper right), and necrosis (upper left). 
 
RESULTS 
 
Verification of Brazilein Content on BCF by 
Thin Layer Chromatography Analysis 
The purpose of o-chemoterapeutic agents 
was to decrease the dose of chemotherapy in order 
to prevent the occurrence of side effect as well as to 
increase the anticancer activity of chemotherapy. 
Prospective chemopreventive activity of CS drived 
to explore the active compound containing in CS. 
Brazilein (Fig. 1A) and Brazilin, two major 
compound of CS possessed potent cytotoxic effect 
toward several cancer cells. In contrary, another 
compound in CS such as chromanone and its 
derivatives exists as estrgonic agent and is possibly 
antagonist the cytotoxic effect of CS (Lai, et al., 
2011). Laksmiani, et al., (2015) had successfull 
isolated brazilein from ethanolic extract of CS, 
however the % yield Brazilein was only 8 %w/w. 
Due to the limitation of isolation techique, 
fractination became a potential approach because of 
its advantages such as, less solvent extraction, 
simple separation technique, and faster than 
isolation. Therefore, in this study we focus explore 
the prospect of BCF as a novel co-chemoterapeutic 
agent. First, we determined the presence of 
Brazilein on BCF by Thin Layer Chromatograpgy. 
Both Be and BFC showed similar hRf value of 65 
under visible light, UV 254 nm, and UV 366 nm 
(Fig. 1B). Therefore, BCF was confrimed to contain 
Be and was valid to be used for cytotoxicity study.  
 
BCF and its Combination with Dox 
Performed Cytotoxic Effect on T47D Cells 
Cytotoxicity of CS correlated with the 
presence of Be content. BCF had been confirmed to 
contain Be, therefore possibly possessed cytotoxic 
effect. T47D was used as a model of breast cancer 
cells and expressed estrogen receptor (ER), 
progesterone receptor, caspase 3, caspase 7, and 
mutated p53  (Schafer, et al., 2000). The 
cytotoxicity study using MTT assay on T47D cells 
was carried out to evaluate the cytotoxicity of 
single tretament BCF and its potency to incerased 
the cytotoxicity of Dox. Single treatment of BCF 
and Dox decreased cells viability in a dose 
dependent manner with IC50 value of 68 µg/mL and 
402 nM, respectively (Fig. 2A and 2B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Phytochemical Profile of Brazilein Containing Fraction (BCF) by Thin Layer Chromatography (TLC). 
A. Chemical Structure of Be. B. TLC profile of Be (i) and BCF (ii). Sample Be and BCF was diluted in ethanol then was 
spotted on Silica Gel GF254. Elution was performed by as mobile phase, then was subjected to visible light and UV 
light. hRf 65 indicated as spot of Be.  
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After combination treatment, various 
concentration of BCF increased cytotoxicity of 
Doxorubicin after 24 h treatment. Intersetingly, 
Both combination of BCF (23 µg/mL) with Dox 
(134 µM) and BCF (34 µg/mL) with Dox (201 µM) 
decreased cells viability up to 15% (Fig. 2C). Under 
isobologram analysisi, all combination of BCF and 
Dox performed synergism (CI<1) and predicted to 
decrease the toxicity of Dox (DRI<1) (Table 1 and 
2). Based on Omoyeni, et al., (2014), BCF was 
classified as strong cytotoxic agent due to the IC50 < 
100 µg/mL. On the other side, IC50 value of 
methanolic extract and ethanolic extract of CS were 
150 and 34 µg/mL, respectively (Nurulita and 
Muflih, 2006; Nurzijah, et al., 2012). Therefore, 
cytotoxicity of BCF was more potent than 
methanolic extract but less potent than ethanolic 
extract of CS. The results indicated that there were 
another compound containing on ethanolic extract 
of CS played role on cytotoxicity of CS beside 
Brazilein and Brazilin. Overall, BCF performed 
strong cytotoxic effect and increased the 
cytotoxicity of Dox on T47D cells. Cytotoxicity of 
BCF need to be confirmed by the cell cycle 
modulation activity and apoptosis induction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Cytotoxicity of BCF in single and its combination on T47D Cells. A. Cytotoxic Effect of BCF on T47D 
Cells. B. Cytotoxic Effect of Dox T47D Cells. Cells were plated on 96-well plates then were treated by single 
treatment of BCF or Dox in various concentration. After regresion analysis, we obtained IC50 values of BCF and 
Dox on T47D was 68 µg/mL and 402 µM. C. Cytotoxic Effect of BCF and Dox Combination on T47D Cells. Cells 
were plated on 96-well plates then were treated by combination of BCF and Dox in various concentration. Data 
expressed as the mean ± standard deviations (SD) from three independent experiments. Statistical data were 
analysed by one way Anova followed by Post Hoc analysis by Tukey (p<0.05) 
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Table 1. Combination Index (CI) Value of BCF and Dox Combination 
 
  
 
 
 
 
 
 
 
 
 
Table 2. Dose Reduction Index (DRI) value of BCF and Dox Combination 
 
 
 
 
 
 
 
 
 
 
 
 
Apoptosis Induction of BCF and its 
Combination with Doxorubicin on T47D 
Cells 
Several chemopreventive and co-
chemoterapeutic agents induced apoptosis through 
intrinsic and extrinsic pathway. CS had been known 
to induced apoptosis on T47D, MCF-7, and HeLa 
cell lines through induction of DNA fragmentation 
and caspase 3 activation (Hung, et al., 2014; 
Khamsita, et al., 2012; Nurzijah, et al., 2012). Dox 
also known to induce apoptosis through increasing 
ROS intracelluer both on cancer cells and normal 
cells (Wang, et al., 2004). Therefore, the used BCF 
was applied in order to diminish the non-selective 
apoptosis induction of Dox. Under, Annexin V PI 
Flowcytometry, we found that single treatment of 
BCF 34 µg/mL was more potent to induce apoptosis 
than Dox 201 nM with precentage cells were 81% 
and 50%,  respectively. However,  BCF also induced 
necrosis with precentage cells were 6%. 
Interestingly, combination of BCF and Dox were 
more potent to induced apoptosis than single 
treatment of both compound with precentage cells 
were 86% and decreased precentage of necrosis cells 
up to 0.05%. Hence, combination of BCF and Dox 
performed cytotoxic effect and performed synergism 
to induce apoptosis (Fig. 3). 
 
 
 
 
 
 
 
 
 
 
  Dox (nM) 
  67 101 134 201 
BC
F 
(µ
g/
m
L)
 17 - 0.81 - - 
23 - - 0.31 - 
34 - - - 0.47 
No 
DRI 
BCF (µg/mL) Dox (nM) 
1 2.27 2.73 
2 6.12 6.76 
3 4.09 4.52 
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Figure 3. Single Treatment of BCF and Its Combination with Dox Induced Apoptosis on T47D Cells.  A. Typical 
quadrant analysis of Annexin V-FITC/Propidium Iodide flowcytometry of T47D cells treated with BCF and its 
combination with Dox. B. Quantification of cell death in each groups. 
 
Apoptotic induction by Doxorubicin requires 
p53 (Drummond, 2008). The p53 gene is a 
suppressor gene tumor that is involved in apoptotic 
induction. T47D cells are cells with mutated p53, so 
it is possible that BCF induce apoptosis via a p53-
independent pathway. One of strategic target on p53-
independent pathway was the inhibition of Bcl-2 
protein. Bcl-2 family proteins were an important 
proteins located on the outer membrane of 
mitochondria due to its role as anti-apoptosis protein 
by increasing the time-to-death and cell-to-cell 
variability (Skommer, et al., 2010). Overexpression 
of Bcl-2 proteins, prevented the release of 
cytochrome c from mitochondria, and was 
responsible for the survival of many types of cancer 
cells such as breast and prostate cancer (Fernández, 
et al., 2002). Therefore, the study of potential role of 
BCF on Bcl-2 protein need to be conducted. 
 
Binding Interaction Profile of Active 
Compound Containing on BCF with Bcl-2 
BCF showed potent cytotoxicity both in 
single and combination with Dox through apoptotic 
induction. The prediction of potential target of BCF 
related to apoptotic induction can be conducted by 
molecular docking. Molecular docking was a 
powerfull tools to predict the interaction of 
compound with receptor. Docking studies were 
performed on anti-apoptotic preotein Bcl-2 (PDB ID: 
4MAN) and compound containg on BCF, Brazilein 
and Brazilin. Navitocalx derivatives, ABT-199, was 
used as a known ligand native possessed as inhibtor 
of anti-apoptosis protein. ABT-199 inhibited the 
growth of Bcl-2–dependent tumors in vivo and 
spares human platelets (Souers, et al., 2013). Based 
on molecular docking PLANTS results, both 
Brazilein and Brazilin performed higher fPLP score 
than native ligand (Table 3). Visualization 
interaction analysis showed that native ligand 
interacted with amino acid residue of PHE 127 and 
ARG 56, however Brazilein only interacted with 
amino acid residue of GLY 151 (Table 3 and Fig. 4). 
Interestingly, Brazilin interacted with more various 
amino acid residue than native ligand and Brazilein 
such as ILE 144, VAL 145, and PHE 150 (Table 3 
and Fig. 4). In general, Brazilein and Brazilin 
interacted with Bcl-2 with different binding 
properties compared to native ligand and possibly 
play role the cytotoxicity of BCF on T47D cells 
through apoptotic induction. 
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Table 3. fPLP Score and Binding Properties of Active Compound of BCF on Bcl-2 
No Ligand fPLP 
score 
 Binding Properties RMSD 
(Å) Ligand Residue Binding Type Distance 
1 ABT-199 (native 
ligand) 
-149.94 N 1323 PHE 127 H-Bond 1.97 2.00 
  O1330 ARG 56 H-Bond 2.49  
2 Brazilein -76.51 N 723 GLY 151 H-Bond 2.09   
3 Brazilin -74.34 O 1287 ILE 144 H-Bond 2.22   
 O 1287 VAL 145 H-Bond 2.07  
 O 1269 PHE 150 H-Bond 2.51  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Visualization Interaction of Brazilein and Brazilin on Bcl-2. A. 3D interaction of Brazilein and Brazilin with 
Bcl-2. Green color represented as hydrophobic binding, Purple color represented as polar bindng, Red color 
represented as exposed binding. B. 2D Ligand interaction of Brazilein and Brazilin with Bcl-2. Purple color 
represented as polar binding, grean color represented as greasy binding.  
 
 
Inhibition of Bcl-2 possessed as strategic 
method to induce apoptosis on p53-mutated cells 
with loss most of pro-apoptotic protein expression 
(Rathore, et al., 2017). Known target of Brazilin on 
apoptotic induction are increasing of cleavage 
caspase 3, cleavage caspase 7 and cleavage PARP 
Interaction (Lee, et al., 2013), while Brazilein 
inhibits the anti-apoptotis protein (Zhong, et al., 
2009). Our findings provided a new target of 
Brazilein and Brazilin underlying the apoptosis 
induction on p53-mutated cells by targeting Bcl-2 
proteins.  Further  research  needs  to  confirm  
chemical or physical interaction of Brazilein and 
Brazilin with anti-apoptotis protein especially Bcl-2 
in order to develop BCF as novel co-
chemoterapeutic agent. 
 
CONCLUSION 
 
Brazilein containing fraction exhibits 
cytotoxic effect and induced apoptosis toward T47D 
cells. 
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